Phase 2 Recurrence Clinical Trials
21 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 21 trials
Recruiting
Phase 2
Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
Acute Myeloid LeukemiaRelapse/Recurrence
Shenzhen University General Hospital10 enrolled1 locationNCT07563179
Recruiting
Phase 2
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
Neoplasm MetastasisEndometrial NeoplasmsNeoplasm Recurrence, Local
Shandong Cancer Hospital and Institute30 enrolled1 locationNCT06532539
Recruiting
Phase 2
Study of Lacutamab in Peripheral T-cell Lymphoma
Relapse/RecurrencePeripheral T Cell Lymphoma
The Lymphoma Academic Research Organisation56 enrolled64 locationsNCT04984837
Recruiting
Phase 2Phase 3
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Prostate CancerMetastatic Prostate CancerOligometastasis+3 more
VA Office of Research and Development464 enrolled20 locationsNCT04787744
Recruiting
Phase 2
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Locoregional Recurrence
Oana Danciu200 enrolled20 locationsNCT05467891
Recruiting
Phase 2
Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
GlioblastomaRecurrence Tumor
Centre Hospitalier Universitaire Vaudois59 enrolled7 locationsNCT07263438
Recruiting
Phase 2
Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled4 locationsNCT07239245
Recruiting
Phase 2
Preoperative Partial Breast Reirradiation and Repeat Breast-conserving Surgery in Patients With Recurrent Breast Cancer: the REPEAT Trial
Recurrent Breast CarcinomaIpsilateral Recurrence
Amsterdam UMC, location VUmc25 enrolled1 locationNCT06640881
Recruiting
Phase 2Phase 3
Secondary Prevention of Clostridioides Difficile Using Vancomycin
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre300 enrolled1 locationNCT06979609
Recruiting
Phase 2
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
Cervical CancerOligometastaticNeoplasm Recurrence, Local
Shandong Cancer Hospital and Institute36 enrolled1 locationNCT06942416
Recruiting
Phase 2
Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy
RadiotherapyLocal Recurrence of Malignant Tumor of Prostate
Maria Sklodowska-Curie National Research Institute of Oncology55 enrolled1 locationNCT06201078
Recruiting
Phase 1Phase 2
B7-H3 NIR Imaging for Osteosarcoma Surgery
OsteosarcomaResection MarginsB7-H3 Probe+1 more
Peking University People's Hospital32 enrolled1 locationNCT06778603
Recruiting
Phase 2
Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery
Hepatocellular Carcinoma (HCC)Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) At High Risk of Recurrence After Curative Resection or Ablation
The First Affiliated Hospital with Nanjing Medical University276 enrolled1 locationNCT06762782
Recruiting
Phase 2
Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
Relapse/RecurrenceAML, ChildhoodRefractory AML+2 more
Children's Hospital of Soochow University50 enrolled12 locationsNCT06316960
Recruiting
Phase 1Phase 2
Immunotherapy for the Treatment of Advanced Solid Tumor
Metastatic CancerSolid TumorRecurrence Tumor
Tongji Hospital40 enrolled1 locationNCT03658785
Recruiting
Phase 2
Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer
Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University40 enrolled1 locationNCT06280508
Recruiting
Phase 2
Dynamic Changes in Circulating Tumour Cells Protein Expression
Recurrence Free Survival
Matteo's Friends150 enrolled1 locationNCT06314997
Recruiting
Phase 2
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
Prostate CancerBiochemical Recurrence
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School102 enrolled2 locationsNCT06305832
Recruiting
Phase 2
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
SurgeryThyroid CancerRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences140 enrolled1 locationNCT06087068
Recruiting
Phase 2
Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
Prostate CancerBiochemical Recurrence
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School96 enrolled2 locationsNCT05753566